CDC Statement on Reprocessing Dental Handpieces
The U.S. Centers for Disease Control and Prevention (CDC) has issued a statement to provide oral healthcare professionals with clear, and consistent guidelines on the best way to reprocess dental handpieces.
The CDC recognizes that the dental community requires clear, consistent guidelines on the best way to reprocess dental handpiece devices between patient encounters. CDC guidelines for infection prevention and control state that, between patients, dental healthcare personnel (DHCP) should clean and heat-sterilize handpieces and other intraoral instruments that can be removed from the air and waterlines of dental units.1 This recommendation is based on studies that have shown that the internal components of air-driven dental handpieces (both low-speed and highspeed devices) can become contaminated with patient material during use, and this material can then be expelled into the mouth of other patients during subsequent uses.2–5 For handpieces and other intraoral instruments that can be removed from the air and waterlines of dental units, CDC continues to recommend that DHCP follow CDC guidelines to clean and heat sterilize.
Dental handpieces are medical devices regulated by the US Food and Drug Administration (FDA). Some handpieces are independent of air and waterlines (e.g., cordless devices). For these devices, CDC recommends that DHCP follow current FDA regulations. DHCP should use FDA-cleared devices6 and follow the validated manufacturer’s instructions for use for reprocessing (cleaning, lubricating, and/or sterilizing) these devices.7
In 2015, FDA released updated guidance for reprocessing medical devices in health care settings[PDF – 805KB]. This guidance gives manufacturers of reusable medical devices recommendations on how to write and scientifically validate reprocessing instructions. Reusable devices that received FDA clearance before 2015 might not have reprocessing instructions that meet the requirements of the 2015 guidance. According to FDA, “reprocessing instructions for some older, legally-marketed, reusable devices may not be consistent with state-of-the-art science and therefore may not ensure that device is clean, disinfected, or sterile.” It is incumbent upon the device manufacturer to provide sufficient instructions on how to prepare devices for use on the next patient.
If a dental handpiece cannot be heat sterilized and does not have FDA clearance with validated instructions for reprocessing, DHCP should not use that device.7 If DHCP are concerned about the validity of the manufacturer’s instructions for reprocessing or believe that the instructions are not consistent with basic infection prevention and control principles, they should contact the manufacturer to request documentation of FDA clearance. If the manufacturer is not able to provide sufficient information, DHCP can contact FDA’s Office of Compliance at OCMedicalDeviceCo@fda.hhs.gov or (240) 402-7675 for assistance.
REFERENCES
- Centers for Disease Control and Prevention. Guidelines for infection control in dental health-care settings—2003[PDF – 1.25 MB]. MMWR Recomm Rep. 2003;52(RR-17):1–61.
- Chin JR, Miller CH, Palenik CJ. Internal contamination of air-driven low-speed handpieces and attached prophy angles. J Am Dent Assoc.2006;137:1275–1280.
- Chin JR, Westerman AE, Palenik CJ, Eckert SG. Contamination of handpieces during pulpotomy therapy on primary teeth. Pediatr Dent.2009;31:71–75.
- Herd S, Chin J, Palenik CJ, Ofner S. The in vivo contamination of air-driven low-speed handpieces with prophylaxis angles. J Am Dent Assoc.2007;138:1360–1365.
- Rutala WA, Weber DJ, and the Healthcare Infection Control Practices Advisory Committee. Guideline for Disinfection and Sterilization in Healthcare Facilities[PDF – 1.26 MB]. Atlanta, GA: Centers for Disease Control and Prevention, US Dept of Health and Human Services; 2008.
- US Food and Drug Administration. 510(k) Premarket Notifications. Accessed March 28, 2018.
- US Food and Drug Administration. Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling. Guidance for Industry and Food and Drug Administration Staff[PDF – 805 KB]. Silver Spring, MD: US Food and Drug Administration, US Dept of Health and Human Services; 2015.
